What should the NPH (Neutral Protamine Hagedorn) insulin dose be for a 60-year-old female with type 2 diabetes, body mass index (BMI) of 29, and severe hyperglycemia, currently receiving tube feeding (TF) with 94 grams of carbohydrates (CHO) over 12 hours and 6 units of Novolog (insulin aspart)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dosing for Severe Hyperglycemia in Tube-Fed Patient

Start NPH insulin at 24-32 units administered in the morning to address the severe hyperglycemia (344 mg/dL) in this patient receiving cycled tube feeding.

Rationale for NPH Dosing Calculation

Given this patient's clinical scenario with severe hyperglycemia despite 6 units of Novolog, a more aggressive basal insulin approach is warranted:

  • For severely hyperglycemic patients, initial insulin dosing should be 0.3-0.4 units/kg/day 1
  • At 81 kg body weight, this calculates to 24-32 units total daily insulin requirement 1
  • NPH should be administered in the morning to provide intermediate-acting coverage that peaks in 4-6 hours, matching the carbohydrate load from the 12-hour cycled tube feeding 2, 3

Specific Dosing Recommendation

  • Initiate NPH at 0.3 units/kg = 24 units given in the morning (conservative starting point) 2
  • For this degree of hyperglycemia (344 mg/dL), consider the higher end: 0.4 units/kg = 32 units 1
  • The 6 units of Novolog already given was inadequate, suggesting significant insulin resistance requiring more aggressive basal coverage 2

Additional Prandial Coverage for Tube Feeding

Since this patient receives 94 grams of carbohydrates over 12 hours in cycled feeding:

  • Add scheduled rapid-acting insulin (Novolog) at 4-6 units every 8 hours to cover the continuous carbohydrate load 4
  • Use a ratio of approximately 1 unit per 10-12 grams of carbohydrate for tube feeding coverage 2, 4
  • This provides approximately 12-18 units of prandial insulin daily in addition to basal NPH 4

Correction Scale for Persistent Hyperglycemia

For blood glucose of 344 mg/dL, the correction insulin was insufficient:

  • Blood glucose 301-350 mg/dL should receive 10-12 units of rapid-acting insulin 2, 4
  • The patient only received 6 units, explaining the inadequate response 2
  • Use correction factor of 1 unit per 20-25 mg/dL above target (using 1800 rule) 2, 4

Monitoring and Titration Protocol

  • Monitor blood glucose every 4-6 hours while adjusting the insulin regimen 2, 4
  • Increase NPH by 2 units every 3 days if fasting glucose remains above 140 mg/dL 3, 4
  • Target blood glucose range: 100-180 mg/dL 2
  • If hypoglycemia occurs, reduce NPH dose by 10-20% 2, 3

Critical Pitfalls to Avoid

  • Do not underdose insulin in severely hyperglycemic patients - the initial 6 units of Novolog was clearly insufficient for a blood glucose of 344 mg/dL 2
  • Failing to provide both basal (NPH) and prandial coverage for tube feeding will result in continued hyperglycemia 4
  • Not timing NPH administration with the tube feeding schedule can lead to hypoglycemia during the 12 hours off feeding 2, 3
  • Monitor closely for hypoglycemia during the 12-hour period when tube feeding is off, as NPH will still be active 3, 4

Special Consideration for BMI 29

  • Patients with BMI >25 typically have insulin resistance requiring higher doses per kilogram 3
  • The calculated dose of 0.3-0.4 units/kg is appropriate and may need further titration upward to 0.5 units/kg (40 units) given the obesity and severe hyperglycemia 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia in Tube-Fed Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.